DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial.

Saved in:
Bibliographic Details
Title: DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial.
Authors: Iyer G; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Tangen CM; Fred Hutchinson Cancer Research Center, Seattle, WA., Sarfaty M; Rabin Medical Center, Petah Tikva, Israel., Regazzi AM; Memorial Sloan Kettering Cancer Center, New York, NY., Lee IL; University of Texas MD Anderson Cancer Center, Houston, TX., Fong M; Johns Hopkins School of Medicine, Baltimore, MD., Choi W; Johns Hopkins School of Medicine, Baltimore, MD., Dinney CPN; University of Texas MD Anderson Cancer Center, Houston, TX., Flaig TW; School of Medicine, University of Colorado, Aurora, CO., Thompson IM Jr; CHRISTUS Medical Center Hospital, UT Health Science Center, San Antonio, TX., Lerner SP; Baylor College of Medicine, Houston, TX., McConkey DJ; Johns Hopkins School of Medicine, Baltimore, MD., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.
Source: JCO precision oncology [JCO Precis Oncol] 2024 Nov; Vol. 8, pp. e2400287. Date of Electronic Publication: 2024 Nov 05.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO.24.00287